PA8615501A1 - Formulaciones farmaceuticas transdermicas - Google Patents

Formulaciones farmaceuticas transdermicas

Info

Publication number
PA8615501A1
PA8615501A1 PA20048615501A PA8615501A PA8615501A1 PA 8615501 A1 PA8615501 A1 PA 8615501A1 PA 20048615501 A PA20048615501 A PA 20048615501A PA 8615501 A PA8615501 A PA 8615501A PA 8615501 A1 PA8615501 A1 PA 8615501A1
Authority
PA
Panama
Prior art keywords
formulations
transdermicas
pharmaceutical formulations
skin
contain
Prior art date
Application number
PA20048615501A
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of PA8615501A1 publication Critical patent/PA8615501A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PROPORCIONAN FORMULACIONES AUTOMIZADAS TRANSDERMICAS QUE CONTIENEN UN AGENTE FARMACEUTICAMENTE ACTIVO Y METODOS PARA SU ADMINISTRACION. LAS FORMULACIONES CONTIENEN UN AGENTE FARMACEUTICO ACTIVO, UN COPOLIMERO VP/VA Y UN VEHICULO NO ACUOSO. ADEMAS LAS FORMULACIONES RECRISTALIZACION DEL AGENTE FARMACEUTICAMENTE ACTIVO Y UN INTENSIFICADOR DE PENETRACION PARA INCREMENTAR LA TASA DE ADMINISTRACION DEL MEDICAMENTO A TRAVES DE LA PIEL. ANTE LA APLICACION EN LA PIEL, LA PRESENTE FORMULACIONES SE SECARAN PARA PROPORCIONAR UNA PELICULA EN EL LUGAR DEL TRATAMIENTO.
PA20048615501A 2003-10-23 2004-10-22 Formulaciones farmaceuticas transdermicas PA8615501A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1122MU2003 2003-10-23

Publications (1)

Publication Number Publication Date
PA8615501A1 true PA8615501A1 (es) 2005-10-25

Family

ID=34531861

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20048615501A PA8615501A1 (es) 2003-10-23 2004-10-22 Formulaciones farmaceuticas transdermicas

Country Status (23)

Country Link
US (1) US20070219171A1 (es)
EP (1) EP1686969A1 (es)
JP (1) JP2007509122A (es)
CN (1) CN100431531C (es)
AP (1) AP2006003628A0 (es)
AR (1) AR046146A1 (es)
AU (1) AU2004285335B2 (es)
BR (1) BRPI0415725A (es)
CA (1) CA2543245A1 (es)
HK (1) HK1098351A1 (es)
IL (1) IL175094A0 (es)
MA (1) MA28167A1 (es)
MX (1) MXPA06004460A (es)
NO (1) NO20062234L (es)
NZ (1) NZ547376A (es)
PA (1) PA8615501A1 (es)
PE (1) PE20050443A1 (es)
RU (1) RU2006117527A (es)
SM (1) SM200400022A (es)
SV (1) SV2006001916A (es)
TW (1) TW200524635A (es)
WO (1) WO2005041943A1 (es)
ZA (1) ZA200604036B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
CN102018671B (zh) * 2011-01-05 2012-07-25 浙江大学 一种雌二醇透皮喷雾剂及其制备方法
US20150065449A1 (en) * 2011-08-12 2015-03-05 Florida State University Research Foundation, Inc. Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG
GB201200062D0 (en) * 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
TWI516281B (zh) * 2014-07-16 2016-01-11 健維生技有限公司 改良之睪固酮製劑製法及所得之睪固酮製劑
EA201891225A1 (ru) * 2015-11-23 2018-11-30 Грейс Терапьютикс Ллк Пленкообразующий спрей для местного применения
EP3737374B1 (en) * 2018-01-10 2024-04-03 Celista Pharmaceuticals Llc Testosterone transdermal spray with film
EP3817731A4 (en) * 2018-07-05 2022-04-06 Celista Pharmaceuticals Llc TRANSDERMAL TESTOSTERONE AND ESTRADIOL SPRAY
CN109432061B (zh) * 2018-11-09 2020-10-30 北京德默高科医药技术有限公司 含有布洛芬或其结构类似物的多层经皮给药系统
CN115154661A (zh) * 2022-07-29 2022-10-11 广州莱度品牌管理有限公司 一种仿生角质膜的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01503281A (ja) * 1987-05-27 1989-11-09 ブルグハルト，クルト 経皮治療に有効な医薬包帯剤およびこれを施用するためのデバイス
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
FR2739031B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
IT1299566B1 (it) * 1998-07-17 2000-03-16 Ifi Istituto Farmacoterapico I Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina
HUP0105336A3 (en) * 1999-02-05 2004-06-28 Cipla Ltd Mumbai Topical spray compositions
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
US6274167B1 (en) * 2000-09-14 2001-08-14 Vincent Margiotta Topical anesthetic patch
US6528040B1 (en) * 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion

Also Published As

Publication number Publication date
SV2006001916A (es) 2006-03-16
WO2005041943A1 (en) 2005-05-12
US20070219171A1 (en) 2007-09-20
IL175094A0 (en) 2006-08-20
CN100431531C (zh) 2008-11-12
HK1098351A1 (en) 2007-07-20
PE20050443A1 (es) 2005-06-14
AR046146A1 (es) 2005-11-23
MA28167A1 (fr) 2006-09-01
AU2004285335B2 (en) 2011-02-10
EP1686969A1 (en) 2006-08-09
NZ547376A (en) 2009-07-31
MXPA06004460A (es) 2006-06-27
ZA200604036B (en) 2007-09-26
KR20070000397A (ko) 2007-01-02
AP2006003628A0 (en) 2006-06-30
CN1897927A (zh) 2007-01-17
BRPI0415725A (pt) 2006-12-19
RU2006117527A (ru) 2007-12-10
AU2004285335A1 (en) 2005-05-12
TW200524635A (en) 2005-08-01
SM200400022B (it) 2005-08-24
JP2007509122A (ja) 2007-04-12
NO20062234L (no) 2006-06-30
CA2543245A1 (en) 2005-05-12
SM200400022A (it) 2005-08-24

Similar Documents

Publication Publication Date Title
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
CY1119059T1 (el) Χρηση προφαρμακων κανναβιδιολης σε τοπικη και διαδερμικη χορηγηση με μικροβελονες
MX2009013574A (es) Formas de dosificacion solidas o semisolidas de liberacion modificada.
MX2015012433A (es) Matriz de microestructura para suministro de agentes activos.
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
MXPA03010991A (es) Composicion permeable a la piel que comprende inhibidor de ciclooxigenasa-a selectivo y alcohol monohidrico.
EA200901112A1 (ru) Жидкие композиции, образующие дермальные пленки, для введения лекарственных препаратов в кожу
WO2008154368A3 (en) Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
CO6311006A2 (es) Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+ efectiva a dosis altas
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
AR062167A1 (es) Sistema de administracion gastrorretentivo
WO2005055921A3 (en) Compositions for treatment of ear disorders and methods of use thereof
PA8615501A1 (es) Formulaciones farmaceuticas transdermicas
AR022589A1 (es) UNA CÁPSULA QUE COMPRENDE UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL, UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL Y EL USO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL CÁNCER
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
BRPI0506630A (pt) composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada
BR0109747A (pt) Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática
CY1125075T1 (el) Εκχυλισμα salvia haenkei σαν δραστικος παραγοντας στις διαδικασιες επανεπιθηλιωσης και επουλωσης ιστων
UA83036C2 (ru) Фармацевтическая композиция в виде гидрогеля для трансдермального введения в организм действующих веществ
ES2572180T3 (es) Formulaciones de liberación controlada que comprenden unidad(es) discreta(s) sin recubrimiento y una matriz de liberación prolongada
ECSP17081071A (es) Composiciones de matriz polimérica tópicas que comprenden una alta concentración de hialuronato de sodio bio-fermentado y sus usos